iShares U.S. Pharmaceuticals ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 6M SHOWN · NET +$486M OVER THIS RANGE
Money keeps arriving — +$186M of net buying over the past month, about 11.0% of the fund's asset base, while the price has returned +27.4% so far this year. At 0.40% a year it is not the cheapest way in — IWM runs the same ground at 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS TODAY’S MOVE · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | JNJJOHNSON & JOHNSON | 22.30% | $273.70 | +1.0% | ||
| 2 | LLYELI LILLY | 21.10% | $1285.72 | +4.8% | ||
| 3 | MRKMERCK & CO | 4.63% | $152.13 | +12.6% | ||
| 4 | BMYBRISTOL MYERS SQUIBB | 4.71% | $67.73 | +2.5% | ||
| 5 | RPRXROYALTY PHARMA | 4.42% | $61.42 | +2.9% | ||
| 6 | PFEPFIZER | 4.25% | $28.22 | +3.5% | ||
| 7 | VTRSVIATRIS | 4.15% | $16.26 | +0.4% | ||
| 8 | ZTSZOETIS | 3.64% | $77.14 | +4.3% | ||
| 9 | JAZZJAZZ PHARMACEUTICALS | 3.42% | $253.74 | +0.3% | ||
| 10 | ELANELANCO ANIMAL HEALTH | 2.59% | $24.49 | +3.6% | ||
| 11 | CORTCORCEPT THERAPEUTICS | 2.46% | $119.55 | +1.3% | ||
| 12 | AXSMAXSOME THERAPEUTICS | 2.05% | $219.67 | +1.8% | ||
| 13 | CRNXCRINETICS PHARMACEUTICALS | 1.96% | $84.74 | -0.0% | ||
| 14 | DFTXDefinium Therapeutics | 1.29% | $45.03 | -2.6% | ||
| 15 | LQDALIQUIDIA | 1.20% | $74.94 | +1.4% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 38| 1 week | +5.0% |
| 1 month | +7.2% |
| 3 months | +23.7% |
| 6 months | +19.6% |
| YTD | +27.4% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | +$21M |
| 1 month | +$186M |
| 3 months | +$622M |
| YTD | +$610M |
| 1 year | +$763M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 22.3% of the book; the top ten carry 75%. Spread across 59+ names, it behaves like roughly 9 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| LLY ELI LILLY | $150M | $88M |
| MRK MERCK & CO | $37M | $40M |
| JNJ JOHNSON & JOHNSON | $21M | $17M |
| PFE PFIZER | $15M | $12M |
| BMY BRISTOL MYERS SQUIBB | $5M | $4M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat IHE on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| IJH iShares Core S&P Mid-Cap ETF | 0.05% | $128.4B | +$547M | -35bp on fee · 76× the assets · +$547M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.7B | +$104M | -36bp on fee · 19× the assets · +$104M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.4B | +$520M | -36bp on fee · 14× the assets · +$520M in over the month | Head-to-head |
| IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF | 0.04% | $18.7B | +$312M | -36bp on fee · 11× the assets · +$312M in over the month | Head-to-head |
| IEFA iShares Core MSCI EAFE ETF | 0.07% | $195.3B | +$631M | -33bp on fee · 116× the assets · +$631M in over the month | Head-to-head |